Recurrent disability progression endpoints in multiple sclerosis clinical trials. Buhler A, Wolbers M, Model F, Wang Q, et al. Mult Scler 2022 Sep 30:13524585221125382. doi: 10.1177/13524585221125382.

Read + Share

Amedeo Smart

Independent Medical Education

Buhler A, Wolbers M, Model F, Wang Q, et al. Recurrent disability progression endpoints in multiple sclerosis clinical trials. Mult Scler 2022 Sep 30:13524585221125382. doi: 10.1177/13524585221125382.
PMID: 36177953